KLP Kapitalforvaltning AS bought a new position in Cabot Co. (NYSE:CBT - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 14,400 shares of the specialty chemicals company's stock, valued at approximately $1,315,000.
Several other institutional investors have also modified their holdings of the stock. Barclays PLC increased its position in Cabot by 103.9% during the third quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company's stock worth $12,699,000 after purchasing an additional 57,907 shares during the last quarter. Franklin Resources Inc. acquired a new stake in shares of Cabot during the 3rd quarter worth approximately $654,000. Delta Financial Group Inc. purchased a new stake in shares of Cabot during the 4th quarter valued at approximately $274,000. Empowered Funds LLC acquired a new position in Cabot in the fourth quarter valued at approximately $1,269,000. Finally, Harbor Capital Advisors Inc. grew its position in Cabot by 20.8% in the fourth quarter. Harbor Capital Advisors Inc. now owns 40,394 shares of the specialty chemicals company's stock worth $3,688,000 after acquiring an additional 6,950 shares during the period. Hedge funds and other institutional investors own 93.18% of the company's stock.
Cabot Trading Down 5.3 %
CBT traded down $4.45 during mid-day trading on Thursday, hitting $79.90. 477,398 shares of the stock were exchanged, compared to its average volume of 378,798. The company has a market cap of $4.33 billion, a PE ratio of 10.61, a PEG ratio of 0.74 and a beta of 1.21. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. The firm's fifty day moving average is $85.05 and its two-hundred day moving average is $97.64. Cabot Co. has a 1-year low of $78.44 and a 1-year high of $117.46.
Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Equities analysts forecast that Cabot Co. will post 7.57 earnings per share for the current fiscal year.
Cabot Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a $0.43 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.72 dividend on an annualized basis and a yield of 2.15%. Cabot's dividend payout ratio (DPR) is presently 22.84%.
Analysts Set New Price Targets
Several equities analysts have recently commented on the company. JPMorgan Chase & Co. decreased their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research note on Friday, February 21st. Mizuho decreased their target price on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research report on Tuesday, January 7th. Finally, StockNews.com upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $97.00.
Check Out Our Latest Stock Analysis on Cabot
Cabot Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Read More

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.